Position in REGN
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$1,332,400,669
+$104,274,465 QoQ
Shares Held
1,724,478
+8.4% QoQ
Ownership
1.64%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 97.88277960055159.ToString("F0")%
None 2.1172203994484127.ToString("F0")%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Invesco Ltd. holds $8,191,566,293 across 258 Biotechnology names. REGN ranks #1 (16.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
1,724,478 | $1,332,400,669 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,561,057 | $1,143,614,384 | |
| 3 | ARGX |
Argenx SE
|
594,697 | $434,277,482 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,291,726 | $427,393,371 | |
| 5 | INCY |
Incyte Corp
|
3,870,764 | $364,316,298 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
4,592,814 | $341,062,362 | |
| 7 | INSM |
INSMED Inc
|
1,988,968 | $325,236,040 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
4,012,494 | $259,327,483 |
All Filings in REGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,332,400,669 | 1,724,478 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $1,228,126,204 | 1,591,105 | Shares | Defined | 2026-02-19 | |
| 2025-09-30 | $834,674,626 | 1,484,473 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $564,807,600 | 1,075,824 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $539,568,628 | 850,746 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $615,630,482 | 864,249 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $1,220,671,495 | 1,161,173 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $963,184,902 | 916,420 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $949,080,581 | 986,068 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $671,897,989 | 765,007 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $611,745,661 | 743,348 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $653,197,400 | 909,062 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $726,976,631 | 884,755 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $499,893,716 | 692,863 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $441,787,477 | 641,322 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $371,340,174 | 628,187 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $421,099,061 | 602,931 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $371,467,004 | 588,211 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $293,172,183 | 484,438 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $256,079,413 | 458,480 | Shares | Defined | 2021-08-17 | |
| 2021-03-31 | $222,065,414 | 469,344 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $192,500,487 | 398,461 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $162,474,459 | 290,247 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $161,605,169 | 259,128 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $147,724,807 | 302,535 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||